Violation Tracker Individual Record

Company: 
Mallinckrodt ARD Inc
Current Parent Company: 
Mallinckrodt
Penalty: 
$100,000,000
Year: 
2017
Date: 
January 18, 2017
Offense Group: 
competition-related offenses
Primary Offense: 
price-fixing or anti-competitive practices
Violation Description: 

Mallinckrodt ARD Inc., formerly known as Questcor Pharmaceuticals, Inc., and its parent company, Mallinckrodt plc, agreed to pay $100 million to settle Federal Trade Commission allegations that they violated the antitrust laws when Questcor acquired the rights to a drug that threatened its monopoly in the U.S. market for adrenocorticotropic hormone (ACTH) drugs.

Level of Government: 
federal
Action Type: 
agency action
Agency: 
Federal Trade Commission
Civil or Criminal Case: 
civil
HQ Country of Parent: 
Ireland
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.